Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 01, 2023 07:30 ET | Source: GBT Technologies Inc.

GBT’s CIP Patent Application of 3D, Multiplanar Photonic Microchips Was Approved for Fast Track

The CIP (Continuation in Part) patent application protects architecture and manufacturing technologies for Photonic, 3D, Multi-Planar integrated circuit technology SAN DIEGO, May 01, 2023 (GLOBE...
April 30, 2023 19:00 ET | Source: MediciNova, Inc.

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-001 for the Treatment of Advanced NASH in Canada

LA JOLLA, Calif., April 30, 2023 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange...
April 27, 2023 10:00 ET | Source: ProStar

ProStar, the World Leader in Developing Precision Mapping Solutions, Has Been Granted Another Significant Patent

GRAND JUNCTION, Colo., April 27, 2023 (GLOBE NEWSWIRE) -- ProStar Holdings Inc. ("ProStar®" or the “Company") (TSXV: MAPS) (OTCQX: MAPPF) (FSE: 5D00) a world leader in Precision Mapping Solutions®,...
April 27, 2023 08:30 ET | Source: BYND Cannasoft Enterprises, Inc.

U.S. Patent filed by BYND Cannasoft to Expand its Artificial Intelligence and Machine Learning Algorithm to a Male Treatment Device

BYND Cannasoft Subsidiary Zigi Carmel Initiatives & Investments LTD. filed U.S. Provisional Patent Application 63461609 on April 25, 2023 covering the mechanical structure, operation, and...
April 26, 2023 07:34 ET | Source: Sixty Degrees Pharmaceuticals

60 Degrees Pharmaceuticals Awarded U.S. Patent Covering Tafenoquine for Treatment of COVID-19 and Other Lung Infections

Patent provides exclusive use through 2040 of tafenoquine for treatment of COVID-19 and other lung infections. Tafenoquine is the active molecule in 60P’s FDA-approved drug for malaria prevention,...
April 26, 2023 07:00 ET | Source: Mindset Pharma Inc.

Mindset Pharma Files Two Patent Applications for its Non-Hallucinogenic Non-Tryptamine Compounds

TORONTO, April 26, 2023 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug discovery company developing novel, optimized,...
April 25, 2023 08:30 ET | Source: BYND Cannasoft Enterprises, Inc.

The Patent Cooperation Treaty (PCT) Provides Positive Opinion on BYND Cannasoft’s AI-Based Female Treatment Device

ASHKELON, Israel and VANCOUVER, British Columbia, April 25, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") announced today it...
April 25, 2023 08:26 ET | Source: ProvisionAI

ProvisionAI Receives Patent for Managing Optimization of a Network Flow

FRANKLIN, Tenn., April 25, 2023 (GLOBE NEWSWIRE) -- ProvisionAI is now the only provider of a patented, optimized replenishment transportation scheduling solution. The patent, “Managing Optimization...
April 25, 2023 08:00 ET | Source: Purdue Research Foundation

Boosting Brown Fat to Combat Obesity and Type 2 Diabetes

WEST LAFAYETTE, INDIANA, April 25, 2023 (GLOBE NEWSWIRE) -- Eat less. Exercise more. It sounds so simple. But if it were that simple, America wouldn’t be facing the dual epidemics of obesity and...
April 25, 2023 07:00 ET | Source: Achilles Therapeutics PLC

Achilles Therapeutics Announces Grant of US Patent Covering the Treatment of Patients with an Immunotherapy Targeting Neoantigens Based on Tumor HLA Status

- Patent broadly covers technology to select neoantigens that are presented by HLA molecules determined to be present in a patient’s tumor - - Patent applies to any modality, including vaccine and...